These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14478866)

  • 1. [The excretion of metachromasia-yielding, coagulation-active substances in the urine after administration of heparin and heparinoids. II. Spectral photometric measurements on aqueous heparintoluidine blue solutions].
    NEJEDLY O; PALM K; WIEDEMANN G
    Hautarzt; 1962 Feb; 13():89-91. PubMed ID: 14478866
    [No Abstract]   [Full Text] [Related]  

  • 2. [Excretion of metachromasia-inducing coagulation-active substances in the urine after administration of heparin and heparinoids. I. Metachromasia as a function of heparin and toluidine blue in distilled water].
    NEJEDLY O; PIPER HG
    Hautarzt; 1961 Feb; 12():77-9. PubMed ID: 13728234
    [No Abstract]   [Full Text] [Related]  

  • 3. Anionic dyes, heparin, and heparinoids: the rediscovery of polyanionic tumor inhibitors.
    Regelson W
    J Natl Cancer Inst; 1989 Dec; 81(24):1929-30. PubMed ID: 2480453
    [No Abstract]   [Full Text] [Related]  

  • 4. Contact activation of prekallikrein and of fibrinolysis by heparinoids and heparin.
    Soulier JP; Gozin D
    Haematologia (Budap); 1980; 13(1-4):117-28. PubMed ID: 6166520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of "heparinoid" substances in urine with a dye-binding technic.
    ROSENFELD L; NEUHOF H; MESTEL AL
    Proc Soc Exp Biol Med; 1961 Jun; 107():317-21. PubMed ID: 13743446
    [No Abstract]   [Full Text] [Related]  

  • 6. The antimitotic activity of polyanions: heparin and heparinoids.
    Regelson W
    J Med; 1974; 5(1):50-68. PubMed ID: 4134041
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacology of heparin and heparinoids.
    Jaques LB
    Prog Med Chem; 1967; 5():139-98. PubMed ID: 4168763
    [No Abstract]   [Full Text] [Related]  

  • 8. [On influencing the physiological coagulation time and the clearing factor by total body inunction with alpha-heparin and heparinoid ointments].
    STUETTGEN G; BRUESTER H
    Dermatol Wochenschr; 1960 Jan; 141():97-102. PubMed ID: 13835417
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the antiphlogistic effect of heparin and heparinoids].
    LAUENSTEIN K; FRIEDRICH H; HABERLAND GL
    Med Exp Int J Exp Med; 1962; 6():200-4. PubMed ID: 14462734
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thrombin time and antithrombin power of human plasma in the presence of heparin and some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    J Physiol (Paris); 1955; 47(1):115-7. PubMed ID: 13243272
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of heparin and heparinoids on platelet aggregation.
    Cepelák V; Roubal Z; Zemanová I; Opatrný K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):750-60. PubMed ID: 6083950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Absence in the diabetic of a urinary factor inhibiting in the normal subject heparin metachromasia in the presence of toluidine blue].
    COTTENOT F; TANRET P
    Bull Mem Soc Med Hop Paris; 1954 Feb 26-Mar 5; 70(7-8):209-11. PubMed ID: 13160787
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyaluronidase inhibition by ointments containing heparin and heparinoids].
    MATHIES H; BURK O
    Med Esp; 1960; 2():329-33. PubMed ID: 13768111
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antithrombin activity and prolongation of thrombin time; comparative study of heparin and of some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    Arch Int Pharmacodyn Ther; 1955 Jun; 102(1-2):96-104. PubMed ID: 13239250
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of the clarifying activity in vitro of serum after the addition of various heparinoid substances].
    WOLFF R; BRIGNON JJ
    Arch Int Pharmacodyn Ther; 1959 Sep; 121():255-67. PubMed ID: 13845713
    [No Abstract]   [Full Text] [Related]  

  • 16. THE EFFECT OF HEPARIN, HEPARINOIDS, AND OTHER ELECTRONEGATIVE COMPOUNDS ON THE IN VITRO THROMBIN-FIBRINOGEN CONVERSION AND ON WHOLE BLOOD CLOTTING TIME.
    SALAFSKY B; LOOMIS TA
    Arch Int Pharmacodyn Ther; 1964 Jul; 150():107-17. PubMed ID: 14204484
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the interaction between blood platelets and heparinoids].
    HOLEMANS R; DEPREZ A
    Rev Hematol; 1960; 15():192-200. PubMed ID: 14402587
    [No Abstract]   [Full Text] [Related]  

  • 18. [HEPARINOIDS--PHYSIOLOGICAL PROPERTIES AND THERAPEUTIC INDICATIONS].
    GUILLEMAN P; HARDY N
    Rev Prat; 1964 Oct; 14():3391-405. PubMed ID: 14205831
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the fibrinolytic effect of heparin and heparinoids].
    Naegeli T; Matis P
    Zentralbl Chir; 1965 Jun; 90(23):881-3. PubMed ID: 4157844
    [No Abstract]   [Full Text] [Related]  

  • 20. The antimitotic activity of polyanions (antitumor, antiviral, and antibacterial action of heparin, heparinoids, anionic dyes, and synthetic polymers).
    Regelson W
    Adv Chemother; 1968; 3():303-70. PubMed ID: 4968881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.